Sarepta says it will continue to ship Elevidys despite FDA requests that it stop shipments of the Duchenne muscular dystrophy ...

Although NOW's strong portfolio and rich partner base are noteworthy, tariffs and stretched valuation are major concerns ...

Discover why Freshworks stands out in SaaS with cost-effective solutions, growth potential, and improving profitability. Click here to read my analysis.

Dave’s stock picks this week are a trio of names that’ve outperformed the market during the past year yet still look ...

The listing could be a major milestone for Figma, coming more than a year after its $20 billion sale to Adobe was terminated due to regulatory hurdles in Europe and the UK. While investors have been ...

HeartFlow plans a $100M IPO to fund R&D and new products despite financial risks. Read about its prospects, challenges, and ...

Guggenheim reaffirmed a "sell" rating on ServiceNow, sticking with a price target of $724, signaling a significant potential ...

In a bold financial play, Forum Financial Management LP ramped up its stake in Morgan Stanley by a whopping 63% during the ...

Bengaluru — Figma is targeting a valuation of $13.65bn in its US initial public offering, as the cloud-based design software ...